Organization · Venture Capital
aMoon Fund
aMoon Fund is a leading HealthTech and Life Sciences investment fund based in Israel, focusing on innovative companies that leverage science and technology to transform healthcare. It invests in both early and late-stage companies.
Overview
What aMoon Fund does
What aMoon Fund is
aMoon Fund is a leading HealthTech and Life Sciences investment fund based in Israel, focusing on innovative companies that leverage science and technology to transform healthcare. It invests in both early and late-stage companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find aMoon Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
aMoon Fund as a funder
Investment thesis
aMoon Fund focuses on transforming healthcare through investments in innovative companies that leverage groundbreaking science and technology, aiming to accelerate the development of solutions for high unmet medical needs.
Focus narrative
aMoon invests in both early and late-stage companies through its aMoon Velocity and aMoon Growth funds. The fund targets disruptive technologies in the healthcare sector, particularly focusing on companies that are generating revenue or are in pivotal clinical trials. Additionally, aMoon has an Edge Fund that invests in IPO and public equity opportunities, fostering partnerships between its portfolio companies and key players in global tech, finance, and medical research.
Value beyond capital
aMoon Fund provides significant value-add to its portfolio companies by leveraging its extensive network in global tech, finance, and medical research, facilitating partnerships that enhance growth and innovation.
Terms and economics
- Typical check
- $1,000,000–$30,000,000
- Sweet spot
- $10,000,000
Focus and fit
- Stages
- Seed · Series A · Series B · Series C · Series D · Growth Equity · Pre-IPO
- Regions
- Asia · Europe · Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- VIRX
Portfolio context
Notable portfolio companies include ACET, AKYA, ADXS, OMDA, SEER, SERA, SOPH, and VIRX, which was acquired by Nanox. Other highlights include DayTwo, Sight Diagnostics, and Ibex Medical Analytics, emphasizing a strong focus on healthcare AI.
Common questions
What to know about aMoon Fund
Upseed classifies aMoon Fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.